Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
Elevara Medicine has raised $70.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.
Elevara Medicine's investors include Sofinnova Partners, Forbion Capital Partners, Monograph Capital, Weatherden.
Elevara Medicine is headquartered in London, United Kingdom.
Elevara is a clinical-stage firm working on innovative therapies to treat rheumatoid arthritis and other chronic inflammatory disorders.
Elevara Medicine is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elevara Medicine — Funding & Investors." VCBacked, October 22, 2025, https://www.vcbacked.co/company/elevara-medicine. Accessed August 1, 2026.
VCBacked. (2025). Elevara Medicine — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/elevara-medicine
{{cite web |title=Elevara Medicine — Funding & Investors |url=https://www.vcbacked.co/company/elevara-medicine |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated